ReviewFrontiers in pharmacology2019

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection.

Núria Climent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.